Troponin T may refine ACS risk stratification; leaves open whether it should guide therapy beyond current standards.
We read with great interest the article in JACC by Lindahl et al. [(1)][1]titled “Mechanisms Behind the Prognostic Value of Troponin T in Unstable Coronary Artery Disease: A FRISC II Substudy.” There is limited data on the coronary anatomy of patients with acute coronary syndromes and an
No takes yet. Share an insight, caveat, or question.
Almeda et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: